Jordan vs Kazakhstan: Hypertension effective treatment coverage (controlled hypertension)
Jordan
32.1%
in 2019
Kazakhstan
30.5%
in 2019
Jordan rank
29th
Kazakhstan rank
32nd
Hypertension effective treatment coverage (controlled hypertension) over time
- Jordan
- Kazakhstan
How they compare
Jordan currently reports 32.1% against 30.5% in Kazakhstan, a difference of 1.6%.
That makes Jordan's figure about 1.1 times Kazakhstan's.
The two have swapped places 2 times across 30 shared years of data; in 1990 it was Jordan ahead.
Jordan ranks 29th and Kazakhstan ranks 32nd of 193 countries.
Jordan has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Jordan | Kazakhstan | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 8.4% | 8.4% | 0.0% | — |
| 2000s | 15.9% | 15.6% | 0.4% | Jordan |
| 2010s | 28.4% | 25.3% | 3.1% | Jordan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension effective treatment coverage (controlled hypertension), Jordan or Kazakhstan?
- Jordan, at 32.1% against 30.5% in Kazakhstan as of 2019.
- What is the difference in hypertension effective treatment coverage (controlled hypertension) between Jordan and Kazakhstan?
- 1.6%, with Jordan ahead.
- How many years of comparable data are there for Jordan and Kazakhstan?
- 30 years are reported by both, from 1990 to 2019.
- How do Jordan and Kazakhstan rank globally for hypertension effective treatment coverage (controlled hypertension)?
- Jordan ranks 29th and Kazakhstan ranks 32nd of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension effective treatment coverage (controlled hypertension )among adults aged 30-79, age-standardized (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.